Dr Minchom completed her medical training in the University of Wales College of Medicine. She trained in medical oncology at the Royal Marsden Hospital. During her training she was awarded an MD(res) for work on mechanisms of resistance to targeted drugs in non-small cell lung cancer.
Dr Minchom is a BRC Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital and the Institute of Cancer Research where she works to develop novel drugs for treating lung cancer and mesothelioma through clinical trials and with translational research. She is principal investigator on national and international first-in-human clinical trials and phase II clinical trials including trials of signalling molecule inhibitors, antibody-drug conjugates, radioimmunoconjugates and immunotherapy.
She also works in the Lung Unit at the Royal Marsden Hospital providing clinical care to patients with lung cancer and mesothelioma.